UnitedHealth Group Incorporated $UNH Stake Boosted by Meiji Yasuda Life Insurance Co

Meiji Yasuda Life Insurance Co increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 68.8% in the 2nd quarter, Holdings Channel.com reports. The fund owned 9,529 shares of the healthcare conglomerate’s stock after buying an additional 3,884 shares during the quarter. UnitedHealth Group comprises about 0.1% of Meiji Yasuda Life Insurance Co’s holdings, making the stock its 27th biggest position. Meiji Yasuda Life Insurance Co’s holdings in UnitedHealth Group were worth $3,961,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Sarver Vrooman Wealth Advisors acquired a new position in UnitedHealth Group in the fourth quarter worth approximately $25,000. Anfield Capital Management LLC grew its position in UnitedHealth Group by 220.0% in the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after acquiring an additional 55 shares in the last quarter. Nalls Sherbakoff Group LLC bought a new position in shares of UnitedHealth Group during the 4th quarter valued at $27,000. Lifetime Wealth Management P.C. acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at $29,000. Finally, Wilkerson Advisory Group LLC bought a new position in UnitedHealth Group during the fourth quarter valued at about $30,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Zacks Research raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Monday, July 13th. Piper Sandler set a $477.00 price target on shares of UnitedHealth Group in a research report on Thursday, July 16th. BMO Capital Markets set a $512.00 price objective on shares of UnitedHealth Group in a report on Tuesday, July 21st. Bank of America reiterated a “buy” rating on shares of UnitedHealth Group in a report on Monday, July 20th. Finally, Wall Street Zen upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $456.56.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 1,169 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.19% of the company’s stock.

UnitedHealth Group Trading Down 0.3%

Shares of UNH stock opened at $393.99 on Friday. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62. The firm’s fifty day simple moving average is $413.28 and its 200 day simple moving average is $360.11. The firm has a market capitalization of $353.64 billion, a P/E ratio of 25.35, a price-to-earnings-growth ratio of 1.36 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.94 by $1.44. The company had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business’s quarterly revenue was up .4% on a year-over-year basis. During the same period last year, the business posted $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 19.82 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be issued a $2.32 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a $9.28 annualized dividend and a yield of 2.4%. UnitedHealth Group’s dividend payout ratio is 59.72%.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.